Boron clusters in medicinal chemistry: perspectives and problems
Author:
- 6 January 2015
- journal article
- Published by Walter de Gruyter GmbH in Pure and Applied Chemistry
- Vol. 87 (2) , 173-179
Abstract
Boron clusters have been employed successfully as constituents in bioactive substances. In this review, the perspectives of boron clusters for drug design and problems to be solved for a broader application are discussed, and a list of actions is given for overcoming the problems.Keywords
This publication has 37 references indexed in Scilit:
- Effect of adenosine modified with a boron cluster pharmacophore on reactive oxygen species production by human neutrophilsBioorganic & Medicinal Chemistry, 2012
- Interaction of dodecaborate cluster compounds on hydrophilic column materials in waterJournal of Chromatography A, 2012
- Synthesis and evaluation of carbaborane derivatives of indomethacin as cyclooxygenase inhibitorsBioorganic & Medicinal Chemistry, 2011
- Cobaltabisdicarbollide anion receptor for enantiomer-selective membrane electrodesChemical Communications, 2009
- Carborane Clusters in Computational Drug Design: A Comparative Docking Evaluation Using AutoDock, FlexX, Glide, and SurflexJournal of Chemical Information and Modeling, 2009
- A novel carborane analog, BE360, with a carbon-containing polyhedral boron-cluster is a new selective estrogen receptor modulator for boneBiochemical and Biophysical Research Communications, 2009
- The Anionic Boron Cluster (B12H11SH)2− as a Means To Trigger Release of Liposome ContentsChemMedChem, 2006
- Self-Assembly of Mercaptane−Metallacarborane Complexes by an Unconventional Cooperative Effect: A C−H···S−H···H−B Hydrogen/Dihydrogen Bond InteractionJournal of the American Chemical Society, 2005
- Taming Superacids: Stabilization of the Fullerene Cations HC 60 + and C 60 ·+Science, 2000
- Preparation and characterization of the (3)-1,2- and (3)-1,7-dicarbadodecahydroundecaborate(-1) ionsJournal of the American Chemical Society, 1968